22 related articles for article (PubMed ID: 38526941)
1. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.
Tepler A; Narula N; Peek RM; Patel A; Edelson C; Colombel JF; Shah SC
Aliment Pharmacol Ther; 2019 Jul; 50(2):121-131. PubMed ID: 31165513
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
[TBL] [Abstract][Full Text] [Related]
5. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.
Rizzato C; Kato I; Plummer M; Muñoz N; Stein A; Jan van Doorn L; Franceschi S; Canzian F
Int J Cancer; 2013 Jul; 133(2):315-22. PubMed ID: 23319424
[TBL] [Abstract][Full Text] [Related]
6. The evolving epidemiology of Helicobacter pylori infection and gastric cancer.
Huang JQ; Hunt RH
Can J Gastroenterol; 2003 Jun; 17 Suppl B():18B-20B. PubMed ID: 12845346
[TBL] [Abstract][Full Text] [Related]
7. The role of CagA status in gastric and extragastric complications of Helicobacter pylori.
Perez-Perez GI; Peek RM; Legath AJ; Heine PR; Graff LB
J Physiol Pharmacol; 1999 Dec; 50(5):833-45. PubMed ID: 10695563
[TBL] [Abstract][Full Text] [Related]
8. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis.
Takahashi-Kanemitsu A; Knight CT; Hatakeyama M
Cell Mol Immunol; 2020 Jan; 17(1):50-63. PubMed ID: 31804619
[TBL] [Abstract][Full Text] [Related]
9. Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis.
Qiao Z; Wang E; Bao B; Tan X; Yuan L; Wang D
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):687-694. PubMed ID: 38526941
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of
Park JY; Forman D; Waskito LA; Yamaoka Y; Crabtree JE
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29671784
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
